Projected Long-Term Clinical Benefit And Cost-Effectiveness Of Empagliflozin Compared With Glimepiride In Patients With Type 2 Diabetes In ChinaMark Lamotte,Ahmed Salem, Sam R. Mettam,Anastasia V. Ustyugova, Edmund Zhang,Mafalda RamosDIABETES（2019）引用 3|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
